Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-02

FDA Approved: LEVETIRACETAM — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

FDA approved Baxter Healthcare Corporation's original-application generic levetiracetam (ANDA 217059) for seizure disorders, establishing a generic version of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levetiracetam (generic) (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)